Results 31 to 40 of about 5,196,368 (357)

Benign and malignant tumors in Rubinstein–Taybi syndrome

American Journal of Medical Genetics. Part A, 2018
Rubinstein–Taybi syndrome (RSTS) is a multiple congenital anomalies syndrome associated with mutations in CREBBP (70%) and EP300 (5–10%). Previous reports have suggested an increased incidence of specific benign and possibly also malignant tumors.
Max V Boot, M. V. van Belzen, L. Overbeek, N. Hijmering, Matias Mendeville, Q. Waisfisz, P. Wesseling, R. Hennekam, D. de Jong   +8 more
semanticscholar   +1 more source

Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors

Frontiers in Neuroscience, 2023
IntroductionThe fifth edition of the World Health Organization (WHO) classification of central nervous system (CNS) tumors released in 2021 formally defines pediatric-type diffuse gliomas.
Wenlin Chen, Shanmu Jin, Shanmu Jin, Qianshu Liu, Qianshu Liu, Hai Wang, Yu Xia, Yu Xia, Xiaopeng Guo, Xiaopeng Guo, Siying Guo, Siying Guo, Yaning Wang, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Yilin Li, Yilin Li, Yuekun Wang, Hao Xing, Junlin Li, Junlin Li, Jiaming Wu, Jiaming Wu, Tingyu Liang, Tian Qu, Tian Qu, Huanzhang Li, Huanzhang Li, Tianrui Yang, Tianrui Yang, Kun Zhang, Kun Zhang, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +37 more
doaj   +1 more source

The paradox of cancer genes in non-malignant conditions: implications for precision medicine. [PDF]

, 2020
Next-generation sequencing has enabled patient selection for targeted drugs, some of which have shown remarkable efficacy in cancers that have the cognate molecular signatures.
Adashek, Jacob J, Kato, Shumei, Kurzrock, Razelle, Lippman, Scott M   +3 more
core  

Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs [PDF]

, 2013
Oncolytic viruses are emerging as a potential new way of treating cancers. They are selectively replication-competent viruses that propagate only in actively dividing tumor cells but not in normal cells and, as a result, destroy the tumor cells by ...
Braidwood, L., Conner, J., Graham, A., Graham, S.V.   +3 more
core   +1 more source

MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer

Frontiers in Oncology, 2022
BackgroundOvertreatment of axillary lymph node dissection (ALND) may occur in patients with axillary positive sentinel lymph node (SLN) but negative non-SLN (NSLN).
Ya Qiu, Ya Qiu, Ya Qiu, Xiang Zhang, Xiang Zhang, Zhiyuan Wu, Shiji Wu, Shiji Wu, Shiji Wu, Zehong Yang, Zehong Yang, Dongye Wang, Dongye Wang, Hongbo Le, Hongbo Le, Jiaji Mao, Jiaji Mao, Guochao Dai, Xuwei Tian, Renbing Zhou, Jiayi Huang, Jiayi Huang, Lanxin Hu, Lanxin Hu, Jun Shen, Jun Shen   +25 more
doaj   +1 more source

Differentiating benign from malignant cardiac tumors with cardiac magnetic resonance imaging

Journal of Thoracic and Cardiovascular Surgery, 2019
Background: The purpose of this analysis is to describe the differences in cardiac magnetic resonance characteristics between benign and malignant tumors, which would be helpful for surgical planning.
M. Kassi, V. Polsani, R. Schutt, Solomon Wong, F. Nabi, M. Reardon, D. Shah   +6 more
semanticscholar   +1 more source

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors

Frontiers in Oncology, 2023
BackgroundThe 5th edition of the World Health Organization (WHO) classification of central nervous system tumors incorporated specific molecular alterations into the categorization of gliomas.
Xiaopeng Guo, Xiaopeng Guo, Yixin Shi, Yixin Shi, Delin Liu, Delin Liu, Yilin Li, Yilin Li, Wenlin Chen, Yaning Wang, Yuekun Wang, Hao Xing, Yu Xia, Yu Xia, Junlin Li, Junlin Li, Jiaming Wu, Jiaming Wu, Tingyu Liang, Hai Wang, Qianshu Liu, Qianshu Liu, Shanmu Jin, Shanmu Jin, Tian Qu, Tian Qu, Siying Guo, Siying Guo, Huanzhang Li, Huanzhang Li, Tianrui Yang, Tianrui Yang, Kun Zhang, Kun Zhang, Yu Wang, Yu Wang, Wenbin Ma, Wenbin Ma   +37 more
doaj   +1 more source

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma. [PDF]

, 2017
Infiltrating low grade gliomas (LGGs) are heterogeneous in their behavior and the strategies used for clinical management are highly variable. A key factor in clinical decision-making is that patients with mutations in the isocitrate dehydrogenase 1 and ...
Berger, Mitchel S, Chang, Susan M, Crane, Jason C, Elkhaled, Adam, Jalbert, Llewellyn E, Kurhanewicz, John, Molinaro, Annette M, Neill, Evan, Nelson, Sarah J, Olson, Marram P, Phillips, Joanna J, Ronen, Sabrina M, Williams, Aurelia   +12 more
core   +1 more source

MALIGNANT TUMOR OF THE TESTICLE. [PDF]

JAMA: The Journal of the American Medical Association, 1907
The recent report1on this subject calls to mind a similar case coming under my own observation. Patient. —J., a brakeman, applied to me, in May, 1900, for relief of what he had been told was hydrocele. Examination. —The left testicle was found to be enlarged to the size ofa lemon; it was fairly firm and not painful.
openaire   +1 more source

HISTOPATHOLOGIC EVALUATION OF ATYPICAL NEUROFIBROMATOUS TUMORS AND THEIR TRANSFORMATION INTO MALIGNANT PERIPHERAL NERVE SHEATH TUMOR IN NEUROFIBROMATOSIS 1 PATIENTS – A CONSENSUS OVERVIEW

Human Pathology, 2017
Neurofibromatosis 1 (NF1) patients develop multiple neurofibromas, with 8–15% of patients experiencing malignant peripheral nerve sheath tumor (MPNST) during their lifetime.
M. Miettinen, C. Antonescu, C. Fletcher, AeRang Kim, A. Lazar, M. Quezado, Karlyne M. Reilly, A. Stemmer-Rachamimov, D. Stewart, D. Viskochil, B. Widemann, A. Perry   +11 more
semanticscholar   +1 more source